Date of Award


Document Type

Project Open Access


A cerebrovascular accident (CVA) more commonly known as a stroke, is a life changing event resulting in impairments that decrease the quality of life.1 Over 795,000 people each year suffer from a stroke and are affected by resulting impairments and disabilities, of these impairments 20% of those affected by a stroke will acquire foot drop.2 Foot drop is due to paralysis or weakness of the ankle dorsiflexor muscles3,4 and therefore describes the inability to actively raise the toes up required to clear the ground during swing phase, resulting in the toes to drag. Foot drop not only causes abnormal gait patterns and compensations, but increases the risk of falls, increases energy expenditure, and potential orthopedic issues up the chain.5-8 Literature has shown the use of ankle foot orthoses (AFOs), transcutaneous functional electrical stimulation (FES), and implantable FES to be effective interventions used to decrease the severity of foot drop in patients post CVA. 8,9 Implantable FES offers an alternative to the transcutaneous e-stim by allowing patients to have a more permanent device to address their foot drop impairment that is more convenient and eliminates the need for daily application. Furthermore, there has been no research in the comparison of transcutaneous FES to implantable FES and their effectiveness on foot clearance during gait for individuals post CVA.